Role of the National Cancer Institute in acquired immunodeficiency syndrome-related drug discovery.
Sausville
E A
EA
Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Shoemaker
R H
RH
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D005381:Financing, Organized; D005544:Forecasting; D019288:Herpesvirus 8, Human / Q000187:drug effects; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration*; D015397:Program Evaluation; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000821:virology; D012984:Software; D014481:United States
D019380:Anti-HIV Agents; D000998:Antiviral Agents